Zylorion Announces Filing of U.S. Provisional Patent For Novel Second-Generation Psilocybin-Based Compound CALGARY, AB, July 14,
Optimi Health Finalizes Psilocybin Supply Agreement With Bloom Psychedelic Therapy and Research Centre JULY 13,
Clinilabs Drug Development Corporation Begins Enrollment for Phase 1/2a Trial Evaluating CYB003 for the Treatment
Filament Health Issued Third Patent by United States Patent and Trademark Office The patent describes
DOSED 2 Screening with Dr. Gabor Maté & Dennis McKenna Q&A Mark your calendar – DOSED
Clairvoyant Initiates First Site for Phase 2 Psilocybin Therapy Clinical Trial for Alcohol Use Disorder
Filament Health Announces Sixth Patent Issuance The patent describes the extraction and standardization of stable
Microdosing Mushrooms: Athlete Perspectives on the Psychedelic Supplement A tiny dose of magic mushrooms might
GOP Congressman’s Amendment Would Direct Military To Study Psilocybin And MDMA Benefits For Service Members
Red Light Holland Update Plans to Enter Oregon Legal Psilocybin Service Market to Promote Diversity
HAVN Life Enters Supply Agreement With MPB Group Inc. This new partnership will see the
Optimi Health Initiates Agreement With Sabi Mind for Therapeutic Supplies of Psilocybin, MDMA JUNE 28,
Ceruvia Lifesciences Receives FDA Investigational New Drug Approval for Psilocybin Obsessive-Compulsive Disorder Program Phase 2
Cybin Receives FDA IND Clearance for its Phase 1/2a Clinical Trial Evaluating CYB003 for the
Oregon County Proposes Ban on Psilocybin Therapy As you likely know, Oregon will become the
Colorado Activists Turn In Signatures To Put Psychedelics Legalization And Therapeutic Psilocybin Program On Ballot
Numinus Applies for International Patent Filing of Psychedelics Production Process Filing would offer added protection
Natural language signatures of psilocybin microdosing The benefits of microdosing can be so subtle that
Nova Mentis Files Patent on Diagnosing, Monitoring and Treating Neurological Diseases with Psychoactive Tryptamine Derivatives
What is wood lovers paralysis? While psychedelic research is rapidly advancing, there’s still a lot
Tryp Therapeutics Announces Results of First Patient Dosed in Its Phase II Clinical Trial for
Optimi Health Finalizes Partnership and Psilocybin Supply Agreement With ATMA Journey Centers Strategic partnership will
Nova Mentis Receives Controlled Substances Export Approval From The U.S DEA For The Company’s Proprietary
Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Stability Test Under a
